Seven Fleet Capital Management LP
Q2 2026 13F filing
Updated 25 days ago114 disclosed positions worth $605.9M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | C CGON CG ONCOLOGY INC | $102.3M | 1.44M | 16.88% | — |
| 2 | T TNGX TANGO THERAPEUTICS INC | $54.4M | 1.91M | 8.99% | — |
| 3 | T TNGX TANGO THERAPEUTICS INC | $41.2M | 1.32M | 6.80% | — |
| 4 | R RVMDW REVOLUTION MEDICINES INC | $36.4M | 194.4K | 6.01% | — |
| 5 | C CGON CG ONCOLOGY INC | $31.7M | 446.8K | 5.24% | — |
| 6 | P PHVS PHARVARIS N V | $16.7M | 482.5K | 2.75% | — |
| 7 | A AAVXF ABIVAX SA | $14.8M | 111.3K | 2.45% | — |
| 8 | E ELVN ENLIVEN THERAPEUTICS INC | $14.7M | 289.1K | 2.42% | — |
| 9 | L LQDA LIQUIDIA CORPORATION | $14.5M | 182.1K | 2.40% | — |
| 10 | M MIRM MIRUM PHARMACEUTICALS INC | $12.9M | 110.4K | 2.13% | — |
| 11 | P PHVS PHARVARIS N V | $10.1M | 292.0K | 1.67% | — |
| 12 | C CYTK CYTOKINETICS INC | $10.1M | 118.2K | 1.66% | — |
| 13 | T TSHA TAYSHA GENE THERAPIES INC | $9.9M | 1.50M | 1.64% | — |
| 14 | R RVMDW REVOLUTION MEDICINES INC | $8.9M | 47.7K | 1.47% | — |
| 15 | M MANE VERADERMICS INC | $8.6M | 70.0K | 1.42% | — |
| 16 | A AVBP ARRIVENT BIOPHARMA INC | $8.6M | 246.6K | 1.41% | — |
| 17 | A AVTX AVALO THERAPEUTICS INC | $8.1M | 438.6K | 1.34% | — |
| 18 | T TARS TARSUS PHARMACEUTICALS INC | $7.9M | 117.1K | 1.31% | — |
| 19 | X XNCR XENCOR INC | $7.8M | 368.3K | 1.29% | — |
| 20 | R ROIV ROIVANT SCIENCES LTD | $7.8M | 220.1K | 1.29% | — |
| 21 | C CRNC CENTURY THERAPEUTICS INC | $7.2M | 2.95M | 1.19% | — |
| 22 | A AXSM AXSOME THERAPEUTICS INC | $7.1M | 28.8K | 1.16% | — |
| 23 | D DFTX DEFINIUM THERAPEUTICS INC | $7M | 148.6K | 1.15% | — |
| 24 | A ASH ASSEMBLY BIOSCIENCES INC | $6.2M | 226.4K | 1.03% | — |
| 25 | A AVTX AVALO THERAPEUTICS INC | $6.1M | 332.2K | 1.01% | — |
| 26 | L LQDA LIQUIDIA CORPORATION | $5.9M | 74.5K | 0.98% | — |
| 27 | C COGT COGENT BIOSCIENCES INC | $5.7M | 147.5K | 0.94% | — |
| 28 | A ASH ASSEMBLY BIOSCIENCES INC | $5.7M | 206.7K | 0.94% | — |
| 29 | P PB PROTAGONIST THERAPEUTICS INC | $5.6M | 45.4K | 0.92% | — |
| 30 | E EIX EDITAS MEDICINE INC | $4.3M | 1.33M | 0.71% | — |
| 31 | D DNTH DIANTHUS THERAPEUTICS INC | $4.3M | 43.7K | 0.70% | — |
| 32 | N NERV MINERVA NEUROSCIENCES INC | $4.2M | 754.4K | 0.69% | — |
| 33 | ? N/A DAMORA THERAPEUTICS INC | $4M | 154.4K | 0.66% | — |
| 34 | E ELVN ENLIVEN THERAPEUTICS INC | $3.9M | 76.3K | 0.64% | — |
| 35 | E EQR ERASCA INC | $3.9M | 210.3K | 0.64% | — |
| 36 | ? N/A SUTRO BIOPHARMA INC | $3.8M | 159.1K | 0.63% | — |
| 37 | C CRNC CENTURY THERAPEUTICS INC | $3.4M | 1.40M | 0.57% | — |
| 38 | ? N/A DAMORA THERAPEUTICS INC | $3.4M | 130.0K | 0.56% | — |
| 39 | R RLAY RELAY THERAPEUTICS INC | $3.3M | 178.2K | 0.55% | — |
| 40 | A ASND ASCENDIS PHARMA A/S | $3.2M | 11.9K | 0.52% | — |
| 41 | S SGMT SAGIMET BIOSCIENCES INC | $3.1M | 403.5K | 0.51% | — |
| 42 | Z ZLAB ZAI LAB LTD | $2.9M | 136.0K | 0.48% | — |
| 43 | C CTMX CYTOMX THERAPEUTICS INC. | $2.7M | 714.0K | 0.44% | — |
| 44 | M MDGL MADRIGAL PHARMACEUTICALS INC | $2.7M | 5.0K | 0.44% | — |
| 45 | C CLDX CELLDEX THERAPEUTICS INC NEW | $2.6M | 70.2K | 0.43% | — |
| 46 | P PRAX PRAXIS PRECISION MEDICINES I | $2.5M | 7.5K | 0.42% | — |
| 47 | R RLMD RELMADA THERAPEUTICS INC | $2.4M | 348.3K | 0.40% | — |
| 48 | E EPRX EUPRAXIA PHARMACEUTICALS INC | $2.2M | 334.8K | 0.37% | — |
| 49 | M MGRB AGIOS PHARMACEUTICALS INC | $2.1M | 56.9K | 0.35% | — |
| 50 | X XENE XENON PHARMACEUTICALS INC | $2.1M | 33.3K | 0.34% | — |